Summarized by Masters of Longevity from Longevity Technology.
Electronic health records compared semaglutide and resmetirom outcomes at three and six months.
Key Takeaways
- The study is observational and was not randomized.
- Researchers reported outcomes at three and six months.
- Record data has short follow-up and potential coding errors.
